Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) Initial FDA Approval: 2016 Side Effect Update Date: November 1, 2024 Medication Description: Treats type 2 diabetes Updated GLP-1 Drugs Side Effects/Safety Information: Warns about the serious risk of pulmonary aspiration during general anesthesia or deep sedation
Most participants were female (60.8%), while males comprised 39.2% of the sample
Your provider sets your starting dose and a gradual step-up plan, personalized to you and documented in your patient portal
That works out to about $49.60 per vial in the three-vial option and about $42.95 per vial in the six-vial option
US$ 22.75
US$ 26.91
US$ 21.79
US$ 26.34
US$ 20.07
US$ 23.61
US$ 27.87
US$ 25.89
US$ 27.69
US$ 27.01
US$ 29.00
